Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Scholz CW, Pinto A, Linkesch W, Linden O, et al. 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial. J Clin Oncol 2012.
PMID: 23233718


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016